Atlas Trials

Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors

Clinical trial NCT01233505 · TERMINATED

Trial details

NCT number
NCT01233505
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Adenocarcinoma of the PancreasAdenocarcinoma of the StomachBRCA1 Mutation CarrierBRCA2 Mutation CarrierOvarian Mucinous CystadenocarcinomaRecurrent Breast CancerRecurrent Colon CancerRecurrent Gastric CancerRecurrent Ovarian Epithelial CancerRecurrent Ovarian Germ Cell TumorRecurrent Pancreatic CancerRecurrent Rectal Cancer
Start date
2010-10-01
Primary completion
2013-10-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.